WebJan 8, 2024 · Cisplatin, carboplatin, and oxaliplatin are the common platinum-based anticancer drugs widely used in the chemotherapeutic treatment of solid tumors in clinic. However, the comprehensive pharmacokinetics of platinum-based anticancer drugs has not been fully understood yet. WebThe microarray data sets for cisplatin- and oxaliplatin-treated A2780 human ovarian cancer cells (GSE8057 ) were obtained from the NCBI GEO database. GSEA was …
Cisplatin-associated neuropathy characteristics compared with …
WebCisplatin is known to produce significant toxicity to both the CNS and PNS, in a cumulative and dose-dependent manner. Carboplatin and oxaliplatin can produce a similar spectrum of neurological toxicities, but to a much lesser extent. The most frequent neurotoxic side-effects of cisplatin involve the PNS (see Chapter 60 ). WebOct 5, 2014 · Cisplatin and oxaliplatin in combination with quercetin and thymoquinone in human ovarian tumour models is the best combination to treat ovarian cancer (Nessa, Beale et al., 2011). Olaparib in combination with Cisplatin has a synergistic effect on PTEN-Deficient lung cancer Cells (Minami, Takigawa et al., 2013). income based apartments tampa florida
Platinum Compounds - an overview ScienceDirect Topics
WebThe microarray data sets for cisplatin- and oxaliplatin-treated A2780 human ovarian cancer cells (GSE8057 ) were obtained from the NCBI GEO database. GSEA was performed for the enrichment of 50 cancer hallmarks. The common and specific cancer hallmarks for cisplatin and oxaliplatin are shown in a Venn diagram (Figure 3A). We … WebAug 1, 2024 · Cisplatin is a standard treatment for head and neck squamous cell carcinoma (HNSCC). Carboplatin is a cisplatin analog with less toxicity that is administered to … WebHowever, the RUNX1 (rs2014300) genotypes were not significantly associated with the OS of patients who received chemotherapy based on cisplatin or oxaliplatin in the dominant models. Therefore, these results demonstrated that 2R/3R and 2R/2R were hazards for patients’ prognosis involving adjuvant chemotherapy based on cisplatin (CDDP). incentive meaning in hrm